Monographie - Oseltamivir - Stabilis 4.0

Senaste uppdateringen :
21/01/2026

Antiviralt medel

Oseltamivir

Oral lösning

Stabilitet av läkemedel

Stabilitet i blandningar

Faktorer som påverkar stabiliteten

Kompatibilitet

Hänvisningar

pdf

Molekylstruktur

Oral lösning

Hänvisningar

Oral lösning

Hänvisningar : Oseltamivir

	Typ	Publikation
2692	tidningen	Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. J Am Pharm Assoc 2007 ; 47, 6; 747-755.
3090	tidningen	Voudrie MA, Brett Allen D. Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution). Int J Pharm Compound 2010 ; 14, 1: 82-85.
3996	tidningen	Dijkers E,Nanhekhan V,Thorissen A. Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil. Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177	tidningen	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526

Mentions Légales